Health ❯ Healthcare ❯ Neurology

Epilepsy

Antiseizure Medications Diagnosis Treatment Options Seizure Frequency Diagnosis and Treatment Treatment AI in Healthcare KCNT1+ Epilepsy MRI Scanning Seizures Causes Gene Activity Profiling Azetukalner Clinical Trials Dravet Syndrome Diagnostic Techniques Cortical Dysplasia Surgery STXBP1-related Disorders Lennox-Gastaut Syndrome Clinical Facilities Absences Cannabis Treatment Surgical Treatments Traumatic Brain Injury Patient Management Brain Lesions Drug-Resistant Epilepsy Outpatient Services Monitoring Systems Human Epilepsy Project Prognosis Bottom-of-Sulcus Dysplasia Seizure Management Absence Epilepsy Medication Management Memory Disorders Treatment-Resistant Epilepsy Focal Epilepsy

SK Biopharmaceuticals Licenses Biohaven’s Opakalim in Deal Worth Up to $795 Million

The agreement transfers development funding and commercial control for a Kv7 epilepsy program to SK pending US antitrust approval.

Long-Term Study Finds Seizure Reductions in Drug-Resistant Focal Epilepsy

Peer-Reviewed Study Finds AI Detects Tiny Epilepsy Lesions in Children With High Accuracy

Capsida Halts STXBP1 Gene Therapy Trial After First Pediatric Participant Dies

Rapport Seizure Drug Posts Strong Phase 2 Signal as Company Plans Phase 3

Subcutaneous EEG Implant Outperforms Self-Reporting in Long-Term Seizure Monitoring

EHR-Based Screening Nearly Doubles Mental Health Assessments in Epilepsy Care